![](https://investorshub.advfn.com/uicon/811563.png?cb=1634766285)
Tuesday, May 10, 2022 9:35:14 AM
Tuesday, May 10, 2022
6:00 AM
6:00 AM - 7:40 AM PDT
Session 5: Unique Challenges in Emerging Immunotherapies
LIVE
Session Chair: George Zavoico, PhD, Cue Biopharma
9:00 AM
Welcome Remarks
Barbara Knappmeyer, PhD, The New York Academy of Sciences
Session 5: Unique Challenges in Emerging Immunotherapies
Session Chair: To be announced
9:10 AM
Immune Checkpoint Blockade in Glioblastoma
David Reardon, MD, Dana Farber Cancer Institute
9:40 AM
How Do CAR T Cells Kill Cancer?
Marcela V. Maus, MD, PhD, Massachusetts General Hospital, Harvard Medical School
10:10 AM
Immunotherapeutic Approaches to Glioblastoma Treatment
Vinay K. Puduvalli, MD, MD Anderson Cancer Center
Virtual session
Join session
8:10 AM
8:10 AM - 9:10 AM PDT
Session 6: Unique Challenges in Emerging Immunotherapies (Continued)
11:10 AM
Autologous Tumor Lysate-loaded Dendritic Cell Vaccination for Glioblastoma
Paul Mulholland, MBBS, MSc, PhD, FRCP, University College Hospital *
11:40 AM
Independent Drug Action in Immunotherapy: Implications for Drug Discovery and Precision Medicine
Peter Sorger, PhD, Harvard Medical School
Virtual session
Included session
9:10 AM
9:10 AM - 9:40 AM PDT
Session 7: Short Talks
12:10 PM
Targeting SIRPa as a Therapeutic Strategy For the Treatment of Breast Cancer Brain Metastasis
Jessica Mackert, PhD, Wake Forest School of Medicine
12:25 PM
Notch Orchestrates A Multifaceted Immune Evasion Program in Hepatocellular Carcinoma
Katherine Linblad, Icahn School of Medicine at Mount Sinai
Virtual session
Included session
11:10 AM
11:10 AM - 12:55 PM PDT
Session 8: Keynote & Session 9: Cytokines as Therapeutics
Session 8: Keynote
Session Chair: George Zavoico, PhD, CueBiopharma
2:10 PM
Cancer and the Immune System
Abul K. Abbas, MBBS, University of California San Francisco School of Medicine
Session 9: Cytokines as Therapeutics
Session Chair: George Zavoico, PhD, CueBiopharma
2:55 PM
Cell Type-Selective Targeting Improves Anti-Tumor Activity and Safety of Cytokines
Ivana Djuretic, PhD, Asher Biotherapeutics
3:25 PM
Expansion of Tumoral CD8 T Cells with a Targeted IL-15 Mutein
Robert C. Rickert, PhD, Pfizer
Featured session
Virtual session
Included session
12:55 PM
12:55 PM - 1:55 PM PDT
Session 10: Poster Session
3:55 PM
Poster Session
4:55 PM
Day 2 - Closing Remarks
Barbara Knappmeyer, PhD, The New York Academy of Sciences
Featured session
Included session
Recent NWBO News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/03/2024 08:01:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/13/2024 08:01:24 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2024 09:06:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/08/2024 08:30:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/02/2024 02:42:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/30/2024 11:49:38 PM
- Biophma Announces Exclusive In License for Dendritic Cell Technology, Sending Shares Higher • AllPennyStocks.com • 06/17/2024 04:40:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 09:11:16 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/03/2024 09:22:55 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/22/2024 08:13:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 09:04:57 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
Reliant Coffee Debuts at #271 on the Inc. 5000 List of Fastest Growing Companies - Coffee Service Industry Disruptor Brews Up Exponential Growth Sep 5, 2024 11:51 AM
VAYK Confirms Receiving Revenue from First Airbnb Property with 1.4 Million Annual Revenue Goal • VAYK • Sep 4, 2024 9:34 AM
Mawson Finland Limited Expands Known Mineralized Zones at Rajapalot: New Lens Intercepts 21.75 m at 5.25 g/t Gold & 515 ppm Cobalt • MFL • Sep 4, 2024 9:02 AM
Integrated Ventures Acquires 51% Stake In GetTrim.Com (TM), Telemedicine Platform With Focus On Expansion Into Booming GLP-1 Powered Weight Loss Market • INTV • Sep 4, 2024 8:45 AM
Avant Technologies Announces Strategic Review Process Intended to Maximize Shareholder Value • AVAI • Sep 4, 2024 8:00 AM
PickleJar Launches National "Get on the Bus" Campaign, Unveils Thompson Square Tour Bus Wrap • PKLE • Sep 4, 2024 7:17 AM